<?xml version="1.0" encoding="UTF-8"?>
<p>Recent discoveries on non-neuronal cholinergic system as a regulator of skin (patho)physiology have drawn attention to the importance of acetylcholinesterase (AChE) in the human skin
 <xref rid="CIT0057" ref-type="bibr">
  <sup>57</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0058" ref-type="bibr">
  <sup>58</sup>
 </xref>. Apart from the extensively known role of AChE in the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of the neurotransmitter acethylcholine, the rationale underlying the use of AChE inhibitors in the symptomatic treatment of Alzheimer’s disease
 <xref rid="CIT0059" ref-type="bibr">
  <sup>59</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0060" ref-type="bibr">
  <sup>60</sup>
 </xref>. Thus, further studies concerning anti-AChE activity 
 <italic>in vitro</italic> will be conducted based on previous reports of high AChE inhibition by some 
 <italic>Plectrathus</italic> spp. aqueous extracts (
 <italic>P. ecklonii</italic>, 
 <italic>P. grandidentatus</italic>, 
 <italic>P. ornatus</italic>, 
 <italic>P. porcatus</italic> and 
 <italic>P. saccatus</italic>) attributed to the presence of rosmarinic (
 <bold>17</bold>) and caffeic acids as major compounds
 <xref rid="CIT0014" ref-type="bibr">
  <sup>14</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0034" ref-type="bibr">
  <sup>34</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0044" ref-type="bibr">
  <sup>44</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0061" ref-type="bibr">
  <sup>61</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0062" ref-type="bibr">
  <sup>62</sup>
 </xref>.
</p>
